Global Fund Board
The Developed Country NGO delegation on the Global Fund Board has issued a call for nominations for the position of Board member. The position has a two-year term: July 2013–June 2015. The deadline for applications is 8 April 2013.
The Global Fund Board has decided that the Affordable Medicines Facility-malaria (AMFm) programme will not continue as a stand-alone programme, but elements will be retained and integrated into the core funding system. The decision was made at the 28th Global Fund Board meeting held in Geneva on 14th and 15th of November.
Implementation of the new funding model approved by the Global Fund Board (see article 4) will roll out in 2013 with a test of the full implementation in about five countries. The lessons from countries that participate in this phase will be absorbed into the NFM as it gains momentum for full implementation for all eligible countries in 2014.
The Global Fund Board has approved a design for the new funding model, though some elements of the design will require further work. The Board has also approved a transition phase for 2013 as a way of testing various elements of the new model. The full model will not likely be rolled out until 2014.
On 14–15 November 2012, the Global Fund Board held its 28th meeting in Geneva, Switzerland. GFO was present, with observer status. The main decisions made at the meeting, in chronological order, were as follows. (For precise wording of what the Board agreed, see the decision points document that has been posted here.
The Global Fund Board has selected Dr Mark Dybul to serve as the Fund’s next Executive Director. He previously served as head of the US President’s Emergency Program for AIDS Relief (PEPFAR). The decision was made by the Board on 15 November at its 28th meeting in Geneva, and the appointment will take effect in early February.
On 12 October 2012, the Global Fund Secretariat submitted a paper containing options and recommendations for the design of the new funding model to the Strategy, Investment and Impact Committee (SIIC) of the Global Fund Board. The SIIC will discuss the paper at its meeting in Geneva of 24–26 October 2012.
The future of the Affordable Medicines Facility–malaria (AMFm) will be decided at the Global Fund Board meeting on 14–15 November 2012. The outcome appears anything but certain. The AMFm was launched as a two-year pilot phase in April 2009 and began operations in July 2010. The AMFm is hosted by the Global Fund but its programme funding comes from other donors.
At the recent Global Fund Board meeting, considerable discussion and energy was devoted to the design of the new funding model (NFM), particularly concerning the issue of how funding would be allocated. The discussions took place during the pre-meeting (12 September) and on both days of the Board meeting itself (13 and 14). Almost 12 hours had been set aside, and were taken, to discuss the new model.
The Global Fund has released its results report for 2012, entitled “Strategic Investments for Impact.” The 94-page report provides comprehensive information on the achievements of programmes supported by the Global Fund through June 2012, and discusses some of the strategic issues the Fund is currently addressing.